Development of a Rapid Test for the Measurement of Kappa and Lambda Free Light Chains in Serum and Urine from Patients with Myeloma Kidney

At present, laboratory free light chain tests offer the only means of quantitating kappa and lambda free light chains (FLC) and have a slow turnaround time that prevents early diagnosis of myeloma kidney, and increases the risk of kidney failure. This poster shows that a new rapid test (Seralite™) is capable of rapidly identifying abnormal FLC levels in blood, providing precise quantitation of FLC is serum and urine within 10 minutes.